Dawn Gammon

676 total citations
11 papers, 254 citations indexed

About

Dawn Gammon is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Dawn Gammon has authored 11 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Dawn Gammon's work include Glioma Diagnosis and Treatment (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Virus-based gene therapy research (2 papers). Dawn Gammon is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Virus-based gene therapy research (2 papers). Dawn Gammon collaborates with scholars based in United States and India. Dawn Gammon's co-authors include Annika van Vollenhoven, Nahid Mohagheghpour, Edgar G. Engleman, L. Masae Kawamura, Claudia Benike, Kathie M. Bishop, Douglas J. Jolly, Marie A. Printz, Raymond T. Bartus and Harry E. Gruber and has published in prestigious journals such as The Journal of Immunology, Clinical Cancer Research and Neurosurgery.

In The Last Decade

Dawn Gammon

10 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn Gammon United States	7	97	95	78	59	55	11	254
Christopher Kelly United States	8	178 1.8×	43 0.5×	45 0.6×	39 0.7×	55 1.0×	16	374
Delphine Nicolle France	8	83 0.9×	66 0.7×	151 1.9×	71 1.2×	23 0.4×	11	331
Saumya Kumar United Kingdom	8	198 2.0×	39 0.4×	158 2.0×	44 0.7×	46 0.8×	14	430
Julian Q. Zhou United States	11	185 1.9×	93 1.0×	133 1.7×	100 1.7×	76 1.4×	23	471
Christina Isaksson Sweden	7	90 0.9×	70 0.7×	81 1.0×	20 0.3×	54 1.0×	9	307
Basel T. Assaf United States	9	88 0.9×	29 0.3×	213 2.7×	86 1.5×	64 1.2×	17	394
Rachel Henry United States	8	105 1.1×	68 0.7×	81 1.0×	27 0.5×	148 2.7×	9	343
Waris Ali Shah Canada	9	46 0.5×	45 0.5×	119 1.5×	131 2.2×	56 1.0×	10	402
Julia Hornig United States	9	91 0.9×	61 0.6×	254 3.3×	92 1.6×	93 1.7×	13	514
Sarah E. Hammond United States	10	96 1.0×	30 0.3×	215 2.8×	32 0.5×	79 1.4×	15	486

Countries citing papers authored by Dawn Gammon

Since Specialization

Citations

This map shows the geographic impact of Dawn Gammon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Gammon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Gammon more than expected).

Fields of papers citing papers by Dawn Gammon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Gammon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Gammon. The network helps show where Dawn Gammon may publish in the future.

Co-authorship network of co-authors of Dawn Gammon

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Gammon. A scholar is included among the top collaborators of Dawn Gammon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Gammon. Dawn Gammon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Accomando, William P., Daniel J. Hogan, Aaron M. Newman, et al.. (2020). Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma. Clinical Cancer Research. 26(23). 6176–6186. 17 indexed citations

Mitchell, Leah, Kader Yagiz, Andrew Hofacre, et al.. (2019). PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models. Oncotarget. 10(23). 2252–2269. 12 indexed citations

Hogan, Daniel J., Jay‐Jiguang Zhu, Oscar R. Diago, et al.. (2018). Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients. Clinical Cancer Research. 24(19). 4680–4693. 23 indexed citations

Accomando, William P., Timothy F. Cloughesy, Steven N. Kalkanis, et al.. (2018). ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA. Neuro-Oncology. 20(suppl_6). vi6–vi7.

Kalkanis, Steven N., Manish K. Aghi, George Kaptain, et al.. (2015). DDEL-06PRELIMINARY SAFETY OF TOCA 511, A RETROVIRAL REPLICATING VECTOR, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ACROSS THREE SEPARATE PHASE 1 STUDIES. Neuro-Oncology. 17(suppl 5). v74.2–v74. 3 indexed citations

Lin, Amy, Christopher R. Logg, Yanzheng Liu, et al.. (2014). MicroRNA 142-3p Attenuates Spread of Replicating Retroviral Vector in Hematopoietic Lineage-Derived Cells While Maintaining an Antiviral Immune Response. Human Gene Therapy. 25(8). 759–771. 4 indexed citations

Herzog, Christopher D., Lamar Brown, Dawn Gammon, et al.. (2009). EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE. Neurosurgery. 64(4). 602–613. 62 indexed citations

Collarini, Ellen J., et al.. (2001). Comparison of methods for erythroblast selection: Application to selecting fetal erythroblasts from maternal blood. Cytometry. 45(4). 267–276. 12 indexed citations

Collarini, Ellen J., et al.. (2001). A novel method for depositing erythroid cells onto glass slides for fetal cell analysis. Cytometry. 45(4). 304–309. 3 indexed citations

10.

Mohagheghpour, Nahid, Dawn Gammon, L. Masae Kawamura, et al.. (1998). CTL Response to Mycobacterium tuberculosis : Identification of an Immunogenic Epitope in the 19-kDa Lipoprotein. The Journal of Immunology. 161(5). 2400–2406. 102 indexed citations

11.

Mohagheghpour, Nahid, et al.. (1997). Mycobacterium aviumReduces Expression of Costimulatory/Adhesion Molecules by Human Monocytes. Cellular Immunology. 176(1). 82–91. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact